Researcher
Guy Laureys
- Keywords:autoimmuniteit, multiple sclerose, neuroinflammatie, Immunologie, Neurologie
- Disciplines:Neurosciences not elsewhere classified, Inflammation, Autoimmunity
Affiliations
- Department of Head and Skin (Department)
Member
From1 Oct 2019 → Today
Projects
1 - 3 of 3
- Charcot Stichting: Research Fund 2019From1 Jan 2022 → 30 Sep 2022Funding: Foundations, funds and other with scientific goal
- ”plug-and-play” design-methodology for medical stickers for sensorsFrom1 Apr 2020 → 31 Dec 2023Funding: VLAIO - Personalised Medicine ICON
- Preclinical evaluation of Vagus Nerve Stimulation as a therapeutic option in Multiple Sclerosis.From1 Nov 2019 → 30 Sep 2022Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 47
- Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies(2024)
Authors: Ying Li, Alice Saul, Bruce Taylor, Anne-Louise Ponsonby, Steve Simpson-Yap, Leigh Blizzard, Simon Broadley, Jeannette Lechner-Scott, Rana Karabudak, Francesco Patti, et al.
Pages: 472 - 485 - Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis(2023)
Authors: Tomas Kalincik, Sifat Sharmin, Mark S. Freedman, Harold Atkins, Joachim Burman, Jennifer Massey, Ian Sutton, Barbara Withers, Richard Macdonell, Andrew Grigg, et al.
Pages: 702 - 713 - Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis(2023)
Authors: Ibrahima Diouf, Charles B. Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, et al.
Pages: 1014 - 1024 - Exome sequencing and multigene panel testing in 1,411 patients with adult-onset neurologic disorders(2023)
Authors: Nika Schuermans, Hannah Verdin, Jody Ghijsels, Madeleine Hellemans, Elke Debackere, Elke Bogaert, Sofie Symoens, Leslie Naesens, Elien Lecomte, David Crosiers, et al.
- Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis(2023)
Authors: C Daruwalla, V Shaygannejad, S Ozakbas, EK Havrdova, D Horakova, R Alroughani, C Boz, F Patti, M Onofrj, A Lugaresi, et al.
Pages: 875 - 883 - The risk of secondary progressive multiple sclerosis is geographically determined but modifiable(2023)
Authors: Sifat Sharmin, Izanne Roos, Steve Simpson-Yap, Charles Malpas, Marina M Sánchez, Serkan Ozakbas, Dana Horakova, Eva K Havrdova, Francesco Patti, Raed Alroughani, et al.
Pages: 4633 - 4644 - Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis(2023)
Authors: Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B. Malpas, Sifat Sharmin, Cavit Boz, Raed Alroughani, Serkan Ozakbas, Katherine Buzzard, Olga Skibina, et al.
Pages: 789 - 797 - Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation(2023)
Authors: Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Olga Skibina, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Jens Kuhle, et al.
Pages: 739 - 748 - A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome(2022)
Authors: Cathérine Dekeyser, Leslie Naesens, Ciel De Vriendt, Alexander Schauwvlieghe, Guy Laureys
- Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity : the Belgian experience(2021)
Authors: Marie D’hooghe, Barbara Willekens, Valerie Delvaux, Miguel D’haeseleer, Daniel Guillaume, Guy Laureys, Guy Nagels, Patrick Vanderdonckt, Vincent Van Pesch, Veronica Popescu